Physician profile
Mark Paiste
NPI 1447567979
$4,209.99
in general payments reported to CMS, 2019-2025
26 companies · $253 in 2025
The $253 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $736 · 2020: $3,134 · 2021: $25.93 · 2022: $29.80 · 2023: $32.05 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes USA Products LLC | $2,824.79 | 2020 | |
| Zimmer Biomet Holdings, INC. | $313.95 | 2019-2021 | |
| Depuy Synthes Sales INC. | $202.35 | 2019-2025 | Dynacord, Healix Knotless Peek |
| Tactile Systems Technology INC | $121.87 | 2019 | |
| Pfizer INC. | $119.92 | 2025 | |
| Axogen | $85.00 | 2020 | |
| Nalu Medical, INC. | $62.18 | 2025 | Nalu Neurostimulation System |
| Ferring Pharmaceuticals INC. | $54.10 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $44.51 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $44.39 | 2019 | |
| Dynasplint Systems INC. | $38.00 | 2019 | |
| Skeletal Dynamics INC | $37.38 | 2019 | |
| Merz North America, INC. | $36.72 | 2019 | |
| Pacira Therapeutics, INC. | $28.20 | 2019-2020 | |
| Abbott Laboratories | $21.83 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $21.82 | 2020 | |
| Djo, LLC | $19.06 | 2019 | |
| Paladin Technology Solutions | $17.57 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.15 | 2020 | |
| Paragon 28, INC. | $15.63 | 2019 | |
| Nevro Corp. | $15.55 | 2019 | |
| Stryker Corporation | $14.79 | 2019 | |
| Kci USA, INC. | $14.49 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.48 | 2023 | Exparel, Iovera, Zilretta |
| Horizon Therapeutics Plc | $12.89 | 2020 | |
| Assertio Therapeutics, INC. | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Paiste listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.